I’m in a new role at this Rosenfeld Media event; I’ve been co-curating Advancing Research 2020 with Lou Rosenfeld, Abby Covert, and Steve Portigal. So, even though I’m not technically on the hook for tripnotes, I’ve enjoyed having a more relaxed approach to capturing some of the key messages coming out of this event. It might be a little patchy in spots, but I hope you enjoy this rough cut of the event … and please check out the conference website for a link to the curated videos, slides, sketchnotes, and official tripnotes.Read More
This week I came across a fantastic commercial from Starbucks related to this topic. It shows a UK teen being called by his deadname repeatedly, until finally he’s asked for his name at Starbucks, and they write his affirmed name on his cup.Read More
This blog post is focused on my chronic health issues, specifically, learning to detox heavy metals using the Andy Cutler Chelation (ACC) protocol. You can read about how I found ACC and chose to pursue it in this post. This is the fourth Chelation Chronicles post, where I am regularly documenting the ups and downs I’m experiencing as I undertake detox from lead and mercury poisoning; you can read the first and second and third chronicles posts, too, if you like.Read More
This is cross-posted from the ZS intranet (which we call ZSpace), where I write episodically about issues of interest to the LGBTQ+ community and our allies. It’s been lightly edited for an external audience.
The Merriam-Webster dictionary recently announced that their word of the year is THEY. You can read their article on the topic here – Word of the Year 2019 | They | Merriam-Webster . Here is a brief excerpt:Read More
This blog post is the sixth in a series on the impact that AI will have on different business aspects of pharma.
While most of us are aware of the importance of user experience, UX goes beyond simply developing a relevant and usable interface for software. UX is a discipline that requires a thorough understanding of users’ needs and the context in which they use technology. Whatever solution you may roll out to users, good UX is about meeting those needs.
With the proliferation of AI-driven solutions and proofs of concept, it’s easy to focus on the data science and forget that what you’re developing eventually needs to serve a person on the job. Within pharma companies, the finished product is often the visualization of complex data that appears in software on a laptop or mobile device. However, if users can’t understand these insights or the insights aren’t valuable to them, then the data science was a wasted effort. That’s where UX comes in. More specifically, that’s why UX should have come in a long time ago.
To better understand the role of UX in developing AI solutions, I spoke with ZS Principal Natalie Hanson, leader of our UX practice, whose team has helped develop multiple AI-driven solutions for clients.Read More